BioAtla (BCAB) Shares Outstanding (Diluted) (2020 - 2026)
BioAtla (BCAB) reported Shares Outstanding (Diluted) of 1.66 million for Q2 2026, down 97.2% from 58.5 million a year earlier but up 10.7% from the prior quarter.
Powered by 
Analysis
BioAtla (BCAB) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025, BioAtla posted Shares Outstanding (Diluted) of 58.83 million, up 21.1% from FY2024.
- Shares Outstanding (Diluted) has increased for five consecutive years, with a five-year compound annual growth rate of 47.5% (FY2020 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 48.57 million in FY2024 (+1.7%), 47.78 million in FY2023 (+22.7%), 38.93 million in FY2022 (+12.6%) and 34.56 million in FY2021 (+310.1%).
- Five-year quarterly Shares Outstanding (Diluted) spans a low of 1.5 million in Q1 2026 and a high of 58.83 million in Q4 2025.
- Year over year, Shares Outstanding (Diluted) gained in six of the last eight quarters, with an average decline of 13.3%.
- The high point for year-over-year Shares Outstanding (Diluted) in five years was Q1 2022 (growth of 342.8%); the low point was Q1 2026 (a decline of 97.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 1.5 million (Q1 2026), 58.83 million (Q4 2025) and 58.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | BioAtla | 2.25 Mn | 2.25 Mn | - | 1.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.66 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 58.83 Mn |
| Sep 30, 2025 | 58.75 Mn |
| Jun 30, 2025 | 58.50 Mn |
| Mar 31, 2025 | 58.25 Mn |
| Dec 31, 2024 | 48.57 Mn |
| Sep 30, 2024 | 48.34 Mn |
| Jun 30, 2024 | 48.21 Mn |
| Mar 31, 2024 | 48.09 Mn |
| Dec 31, 2023 | 47.78 Mn |
| Sep 30, 2023 | 47.83 Mn |
| Jun 30, 2023 | 47.71 Mn |
| Mar 31, 2023 | 47.58 Mn |
| Dec 31, 2022 | 38.93 Mn |
| Sep 30, 2022 | 37.52 Mn |
| Jun 30, 2022 | 37.42 Mn |
| Mar 31, 2022 | 37.32 Mn |
| Dec 31, 2021 | 34.56 Mn |
| Sep 30, 2021 | 33.91 Mn |
API Access
BioAtla Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();